Abvc Biopharma (ABVC) Operating Margin Growth (5y) (2016 - 2025)
Abvc Biopharma (ABVC) Operating Margin Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.20 Bn | 131.35 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.09 Bn | 78.10 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.25 Bn | 60.07 Bn | 1.37 Bn |
| 4 | Moderna | 59.04 Bn | 53.90 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.04 Bn | 36.94 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.04 Bn | 9.65 Bn | 668.28 Mn |
| 8 | Insmed | 27.50 Bn | 26.33 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.34 Bn | 26.50 Bn | - |
| 10 | Abvc Biopharma | 22.93 Mn | 22.93 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 808,705.00 |
| Dec 31, 2024 | -3.47 Mn |
| Sep 30, 2024 | 48,655.00 |
| Jun 30, 2024 | -47,937.00 |
| Mar 31, 2024 | -23.52 Mn |
| Dec 31, 2023 | 1.63 Mn |
| Sep 30, 2023 | 3.95 Mn |
| Jun 30, 2023 | -1.97 Mn |
| Mar 31, 2023 | 524,114.00 |
| Jun 30, 2022 | -18,055.00 |
| Dec 31, 2021 | 193,859.00 |
| Dec 31, 2016 | 2.21 Mn |